SEC Form 4 · accession 0001179110-15-013022
GILEAD SCIENCES, INC. · GILD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robin L Washington
Officer — EVP, CFO
Period of report
Sep 2, 2015
Accepted (ET)
Sep 3, 2015 · 3:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000882095
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Sep 2, 2015 | S | 3,000 | $101.7537 | D | 97,546 | I | Trust |
| Common StockF3 | Sep 2, 2015 | S | 3,150 | $102.5954 | D | 94,396 | I | Trust |
| Common Stock | Sep 2, 2015 | S | 100 | $103.41 | D | 94,296 | I | Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
- F2Sale prices reported for the transactions reported here range from $101.16 to $102.12. Full information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
- F3Sale prices reported for the transactions reported here range from $102.22 to $103.06. Full information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.